Harsch Mutya (CIK 0001727809)

Latest company ownership

VYNE - VYNE Therapeutics Inc.
Role: CHIEF LEGAL OFFICER AND GC
Shares held
129,484
Last filed at
Oct 2, 2025
Confidence Score
49.4
2025Q4
Confidence Score History
2020Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 30, 2025 Oct 2, 2025 VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Sell 47.5 -3,581 -2.69% ✗ $1.2K
Jun 30, 2025 Jul 2, 2025 VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Sell 47.5 -3,581 -2.62% ✗ $5.9K
Mar 31, 2025 Apr 2, 2025 VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Sell 46.3 -8,828 -6.12% ✗ $13.9K
Dec 31, 2024 Jan 2, 2025 VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Sell 46.3 -4,697 -3.15% ✗ $15.7K
Sep 30, 2024 Oct 2, 2024 VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Sell 52.5 -105 -0.07% ✗ $197.4
Jul 1, 2024 Jul 3, 2024 VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Sell 52.5 -143 -0.10% ✗ $274.6
Apr 1, 2024 Apr 3, 2024 VYNE Therapeutics Inc. CHIEF LEGAL OFFICER AND GC Sell 52.5 -161 -0.11% ✗ $495.9
Jan 1, 2024 Jan 3, 2024 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 90.0 +62,339 71.58% ✗ $367.1
Oct 2, 2023 Oct 4, 2023 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 47.5 -1,154 -4.48% ✗ $4.4K
Jun 30, 2023 Jul 5, 2023 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -157 -0.61% ✗ $643.7
Mar 31, 2023 Apr 4, 2023 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 47.5 -478 -2.10% ✗ $1.5K
Mar 20, 2023 Mar 22, 2023 VYNE Therapeutics Inc. Chief Legal Officer and GC Buy 91.3 +10,000 78.61% ✗ $25K
Dec 31, 2022 Jan 4, 2023 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,813 -0.78% ✗ $272
Sep 30, 2022 Oct 4, 2022 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,813 -0.78% ✗ $404.3
Jun 30, 2022 Jul 5, 2022 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,813 -0.77% ✗ $705.3
Mar 31, 2022 Apr 4, 2022 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 47.5 -3,630 -1.52% ✗ $2.4K
Dec 31, 2021 Jan 4, 2022 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,484 -0.90% ✗ $1.5K
Sep 30, 2021 Oct 1, 2021 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,484 -0.89% ✗ $2.1K
Jun 30, 2021 Jul 2, 2021 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 46.3 -3,551 -3.26% ✗ $12.5K
Mar 31, 2021 Apr 2, 2021 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 46.3 -1,765 -1.60% ✗ $12.1K
Dec 31, 2020 Jan 5, 2021 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,822 -0.56% ✗ $2.9K
Sep 30, 2020 Oct 2, 2020 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,822 -0.57% ✗ $3K
Jun 30, 2020 Jul 2, 2020 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 50.0 -1,822 -0.57% ✗ $3.2K
Apr 3, 2020 Apr 7, 2020 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 90.0 +114,209 202.13% ✗ $6.3K
Mar 31, 2020 Apr 2, 2020 VYNE Therapeutics Inc. Chief Legal Officer and GC Sell 47.5 -1,688 -2.90% ✗ $4.5K